Eagle Pharmaceuticals Inc. Share Price Today: Live Updates & Key Insights
Eagle Pharmaceuticals Inc. share price today is $2.275, up -39.89%. The stock opened at $2.78 against the previous close of $3.56, with an intraday high of $2.8 and low of $1.8.
Eagle Pharmaceuticals Inc. Share Price Chart
Eagle Pharmaceuticals Inc.
Eagle Pharmaceuticals Inc. Share Price Performance
Eagle Pharmaceuticals Inc. Institutional Holdings
Eagle Pharmaceuticals Inc. Market Status
Eagle Pharmaceuticals Inc. Fundamentals
Market Cap 46.13 M
PB Ratio 0.1825
PE Ratio 4.1882
Enterprise Value 102.26 M
Total Assets 406.16 M
Volume 4664101
Eagle Pharmaceuticals Inc. Company Financials
About Eagle Pharmaceuticals Inc. & investment objective
Company Information Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a ready-to-use/dilute liquid form of pemetrexed for non-small cell lung cancer and mesothelioma; EA-114 (fulvestrant) for HR+/HER- breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an antitoxin agent for the treatment of severe pneumonia in combination with traditional antibacterial drugs; and AOP Orphan Pharmaceuticals GmbH for the commercial rights of Landiolol, a novel therapeutic product candidate for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat breast cancer (HR+/HER2-) and high-risk metastatic sarcomas. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.
Organisation Drug Manufacturers - Specialty & Generic
Employees 134
Industry Drug Manufacturers - Specialty & Generic
CEO null
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Eagle Pharmaceuticals Inc. FAQs
What is the share price of Eagle Pharmaceuticals Inc. today?
The current share price of Eagle Pharmaceuticals Inc. is $2.275.
Can I buy Eagle Pharmaceuticals Inc. shares in India?
Yes, Indian investors can buy Eagle Pharmaceuticals Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Eagle Pharmaceuticals Inc. shares in India?
You can easily invest in Eagle Pharmaceuticals Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Eagle Pharmaceuticals Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Eagle Pharmaceuticals Inc..
Can I buy fractional shares of Eagle Pharmaceuticals Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Eagle Pharmaceuticals Inc.?
Eagle Pharmaceuticals Inc. has a market cap of $46.13 M.
In which sector does Eagle Pharmaceuticals Inc. belong?
Eagle Pharmaceuticals Inc. operates in the Drug Manufacturers - Specialty & Generic sector.
What documents are required to invest in Eagle Pharmaceuticals Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Eagle Pharmaceuticals Inc.?
The PE ratio of Eagle Pharmaceuticals Inc. is 4.19 and the PB ratio is 0.18.